News summary10x Genomics Investor RelationsNov 5, 2026, 12:00 PM
10x Genomics reports Q3 results and raises 2026 revenue guidance
On November 5, 2026, 10x Genomics reported Q3 revenue of $150.7 million, up 1% year over year, and raised FY 2026 revenue guidance to $625–$635 million from $610–$630 million. It began global commercial shipments of its Atera platform.